Filing Details

Accession Number:
0001104659-21-055582
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-27 16:03:37
Reporting Period:
2021-04-26
Accepted Time:
2021-04-27 16:03:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1173281 Neubase Therapeutics Inc. NBSE Pharmaceutical Preparations (2834) 465622433
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1313876 I Eric Richman C/O 350 Technology Drive, Fourth Floor
Pittsburgh PA 15219
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-26 5,000 $5.00 41,080 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 27,747 Indirect See footnote
Footnotes
  1. The power of attorney under which this form was signed is on file with the Commission.
  2. Shares are held in a trust for the benefit of the reporting person with the reporting person and the reporting person's spouse serving as co-trustees.